Literature DB >> 11511841

Dapsone and sulfones in dermatology: overview and update.

Y I Zhu1, M J Stiller.   

Abstract

In their 60-year history, dapsone and the sulfones have been used as both antibacterial and anti-inflammatory agents. Dapsone has been used successfully to treat a range of dermatologic disorders, most successfully those characterized by abnormal neutrophil and eosinophil accumulation. This article reviews and updates the chemistry, pharmacokinetics, clinical application, mechanism of action, adverse effects, and drug interactions of dapsone and the sulfones in dermatology.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11511841     DOI： 10.1067/mjd.2001.114733

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  69 in total

1.  A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

Review 2.  Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature.

Authors:  Céline Roman; Bogdan Dima; Laurence Muyshont; Thierry Schurmans; Olivier Gilliaux
Journal:  Eur J Pediatr       Date:  2019-06-22       Impact factor: 3.183

Review 3.  Activity of Dapsone versus Community and Hospital Pathogens from the CANWARD Study.

Authors:  George G Zhanel; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-03-01

4.  Evaluation of the efficacy of intralesional Glucantime plus niosomal zinc sulphate in comparison with intralesional Glucantime plus cryotherapy in the treatment of acute cutaneous leishmaniasis, a randomized clinical trial.

Authors:  Saeedeh Farajzadeh; Rahim Ahmadi; Saman Mohammadi; Abbas Pardakhty; Maryam Khalili; Mahin Aflatoonian
Journal:  J Parasit Dis       Date:  2018-10-13

5.  Letter to the editor: Application of dapsone 5% gel in a patient with dermatitis herpetiformis.

Authors:  Marc Z Handler; Anna H Chacon; Michael I Shiman; Lawrence A Schachner
Journal:  J Dermatol Case Rep       Date:  2012-12-31

6.  A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.

Authors:  Viswanath R Belum; Michael A Marchetti; Stephen W Dusza; Andrea Cercek; Nancy E Kemeny; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-09       Impact factor: 11.527

7.  A Young Woman With Sudden Urinary Retention and Sensory Deficits.

Authors:  Sarah L Patterson; Kashif Jafri; Jared A Narvid; Mary Margaretten
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02-18       Impact factor: 4.794

8.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

9.  Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis.

Authors:  Wimonchat Tangamornsuksan; Manupat Lohitnavy
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

10.  [Cutis verticis gyrata-like acne inversa. Combined medical and surgical management].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2009-04       Impact factor: 0.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.